These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8392922)

  • 21. [Pathogenesis of diabetic neuropathies].
    Lalau JD; Arlot S; Quichaud J
    Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.
    Berti-Mattera L; Day N; Peterson RG; Eichberg J
    Metabolism; 1996 Mar; 45(3):320-7. PubMed ID: 8606638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol-3-phosphate and inositol phosphates in mitogenesis.
    Poyner D; Hawkins P; Hanley M
    Biochem Soc Trans; 1990 Jun; 18(3):450-1. PubMed ID: 2164991
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucocorticoids inhibit formation of inositol phosphates in macrophages.
    Fitzke E; Dieter P
    Biochem Biophys Res Commun; 1991 Aug; 178(3):974-9. PubMed ID: 1651724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakdown of polyphosphoinositides and not phosphatidylinositol accounts for muscarinic agonist-stimulated inositol phospholipid metabolism in rat parotid glands.
    Downes CP; Wusteman MM
    Biochem J; 1983 Dec; 216(3):633-40. PubMed ID: 6320795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced arterial contractility to noradrenaline in diabetic rats is associated with increased phosphoinositide metabolism.
    Abebe W; MacLeod KM
    Can J Physiol Pharmacol; 1991 Mar; 69(3):355-61. PubMed ID: 1647847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal inositol phospholipid metabolism in diabetes].
    Hashimoto T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():210-5. PubMed ID: 12355749
    [No Abstract]   [Full Text] [Related]  

  • 28. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inositol treatment in medicine].
    Levine J; Grisaru N
    Harefuah; 1996 May; 130(9):630-4. PubMed ID: 8794646
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin reverses enhanced incorporation of 32P into polyphosphoinositides in peripheral nerve of the streptozotocin diabetic rat.
    Berti-Mattera LN; Peterson RG; Eichberg J
    J Neurochem; 1986 Dec; 47(6):1932-5. PubMed ID: 3021909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetic neuropathy--a review of pathological studies].
    Kito S; Yamamura Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():152-8. PubMed ID: 1851895
    [No Abstract]   [Full Text] [Related]  

  • 32. Alteration of phosphoinositide metabolism, protein phosphorylation, and carbohydrate levels in sciatic nerve from Wistar fatty diabetic rats.
    Berti-Mattera LN; Lowery J; Day SF; Peterson RG; Eichberg J
    Diabetes; 1989 Mar; 38(3):373-8. PubMed ID: 2537246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of inositol lipid metabolism of rat sciatic nerve in streptozotocin-induced diabetes.
    Natarajan V; Dyck PJ; Schmid HH
    J Neurochem; 1981 Feb; 36(2):413-9. PubMed ID: 7463069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor activation and inositol lipid hydrolysis in neural tissues.
    Fisher SK; Agranoff BW
    J Neurochem; 1987 Apr; 48(4):999-1017. PubMed ID: 3029333
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.
    Berridge MJ
    Biochem J; 1983 Jun; 212(3):849-58. PubMed ID: 6309155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of D-myo-inositol transport in diabetic rat glomerular cells.
    Whiteside CI; Thompson JC
    Am J Physiol; 1992 Mar; 262(3 Pt 1):E301-6. PubMed ID: 1312787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased polyphosphoinositide metabolism accompanies myelinated fiber loss in human peripheral neuropathies.
    Berti-Mattera LN; Harati Y; Eichberg J
    Mol Chem Neuropathol; 1992 Dec; 17(3):201-8. PubMed ID: 1337252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal sciatic nerve myo-inositol metabolism in the streptozotocin-diabetic rat: effect of insulin treatment.
    Clements RS; Stockard CR
    Diabetes; 1980 Mar; 29(3):227-35. PubMed ID: 6247233
    [No Abstract]   [Full Text] [Related]  

  • 39. Phosphatidylinositol and inositol phosphate metabolism.
    Abel K; Anderson RA; Shears SB
    J Cell Sci; 2001 Jun; 114(Pt 12):2207-8. PubMed ID: 11493657
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function.
    Greene DA
    Metabolism; 1983 Jul; 32(7 Suppl 1):118-23. PubMed ID: 6306391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.